ACADIA Pharmaceuticals Inc (ACAD)
Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell
$17.52
Buy
$17.53
$0.625 (+3.70%)
Prices updated at 15 Jan 2025, 19:36 EST
| Prices minimum 15 mins delay
Prices in USD
ACADIA Pharmaceuticals Inc is a biotechnology company which develops and commercializes biopharmaceutical products to address central nervous system disorders. It aims to discover small molecule drugs to address Parkinson’s, Alzheimer’s and schizophrenia.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2023 | 94.27 |
| 2022 | 98.03 |
| 2021 | 96.05 |
| 2020 | 95.35 |
| 2019 | 94.22 |
| 2018 | 91.81 |
| 2017 | 89.54 |
| 2016 | 74.58 |
Valuation data table
Year | Price / Sales |
|---|---|
| 2025 | 3.02 |
| 2024 | 3.27 |
| 2023 | 8.08 |
| 2022 | 5.04 |
| 2021 | 7.85 |
| 2020 | 19.92 |
| 2019 | 20.15 |
| 2018 | 9.70 |
| 2017 | 39.33 |
| 2016 | 593.56 |
| 2015 | 38,621.16 |
Price/Forward earnings (YTD)
23.47
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2023 | -9.17 |
| 2022 | -33.54 |
| 2021 | -22.64 |
| 2020 | -35.97 |
| 2019 | -35.55 |
| 2018 | -53.03 |
| 2017 | -61.21 |
| 2016 | -69.32 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2023 | 1.73 |
| 2022 | 1.47 |
| 2021 | 1.29 |
| 2020 | 1.25 |
| 2019 | 1.12 |
| 2018 | 1.13 |
| 2017 | 1.15 |
| 2016 | 1.08 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
